We have located links that may give you full text access.
Cosmetic improvement of nevus of Ota by scleral allograft overlay.
OBJECTIVE: To report surgical outcome of a new therapeutic technique for nevus of Ota by scleral allograft overlay.
DESIGN: Noncomparative clinical interventional study.
PARTICIPANTS: Eight eyes of 7 patients with scleral nevus of Ota.
METHODS: Patients underwent subconjunctival scleral allograft overlay between September 2005 and June 2007 at Seoul National University Hospital. Preoperative neval extent, postoperative cosmesis, complications, and visual acuity change were evaluated.
RESULTS: Most of the patients showed satisfying cosmetic improvement. There were no significant complications in a follow-up period of more than 3 years.
CONCLUSIONS: Scleral allograft overlay is a safe and effective procedure for cosmetic improvement of nevus of Ota.
DESIGN: Noncomparative clinical interventional study.
PARTICIPANTS: Eight eyes of 7 patients with scleral nevus of Ota.
METHODS: Patients underwent subconjunctival scleral allograft overlay between September 2005 and June 2007 at Seoul National University Hospital. Preoperative neval extent, postoperative cosmesis, complications, and visual acuity change were evaluated.
RESULTS: Most of the patients showed satisfying cosmetic improvement. There were no significant complications in a follow-up period of more than 3 years.
CONCLUSIONS: Scleral allograft overlay is a safe and effective procedure for cosmetic improvement of nevus of Ota.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app